Evidence map›Paper›PMID 30253175›Full record

ArticleNeuropharmacology2019

Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.

Jiann W Yeoh, Morgan H James, Cameron D Adams, Jaideep S Bains, Takeshi Sakurai, Gary Aston-Jones, Brett A Graham, Christopher V Dayas

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Jiann W YeohSchool of Biomedical Sciences & Pharmacy, Centre for Brain and Mental Health Research, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia.
Morgan H JamesBrain Health Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, USA; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Cameron D AdamsSchool of Biomedical Sciences & Pharmacy, Centre for Brain and Mental Health Research, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia.
Jaideep S BainsHotchkiss Brain Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
Takeshi SakuraiDepartment of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Kanazawa-shi, Ishikawa, 920-8640, Japan.
Gary Aston-JonesBrain Health Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Brett A GrahamSchool of Biomedical Sciences & Pharmacy, Centre for Brain and Mental Health Research, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia.
Christopher V DayasSchool of Biomedical Sciences & Pharmacy, Centre for Brain and Mental Health Research, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia. Electronic address: christopher.dayas@newcastle.edu.au.
Hunter Medical Research Institute · AURutgers, The State University of New Jersey · USKanazawa University · JPUniversity of Calgary · CA

Funding

ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTIONR01DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 1989 to 2024
$6.0M
Orexin/hypocretin as a common mediator of stress and reward behavior in cocaine addictionR00DA045765 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JAMES, MORGAN H. · 2021 to 2023
$747k
Orexin/hypocretin as a common mediator of stress and reward behavior in cocaine addictionK99DA045765 · NIDA · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI JAMES, MORGAN H. · 2019 to 2020
$388k
NIDA NIH HHS K99 DA045765NIDA NIH HHS R00 DA045765NIDA NIH HHS R01 DA006214
6 · The paper itself

Abstract

The perifornical/lateral hypothalamic area (LHA) orexin (hypocretin) system is involved in drug-seeking behavior elicited by drug-associated stimuli. Cocaine exposure is associated with presynaptic plasticity at LHA orexin cells such that excitatory input to orexin cells is enhanced acutely and into withdrawal. These changes may augment orexin cell reactivity to drug-related cues during abstinence and contribute to relapse-like behavior. Studies in hypothalamic slices from drug-naïve animals indicate that agonism of group III metabotropic glutamate receptors (mGluRs) reduces presynaptic glutamate release onto orexin cells. Therefore, we examined the group III mGluR system as a potential target to reduce orexin cell excitability in-vivo, including in animals with cocaine experience. First, we verified that group III mGluRs regulate orexin cell activity in behaving animals by showing that intra-LHA infusions of the selective agonist L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4) reduces c-fos expression in orexin cells following 24 h food deprivation. Next, we extended these findings to show that intra-LHA L-AP4 infusions reduced discriminative stimulus-driven cocaine-seeking following withdrawal. Importantly, L-AP4 had no effect on lever pressing for sucrose pellets or general motoric behavior. Finally, using whole-cell patch-clamp recordings from identified orexin cells in orexin-GFP transgenic mice, we show enhanced presynaptic drive to orexin cells following 14d withdrawal and that this plasticity can be normalized by L-AP4. Together, these data indicate that activation of group III mGluRs in LHA reduces orexin cell activity in vivo and may be an effective strategy to suppress cocaine-seeking behavior following withdrawal. These effects are likely mediated, at least in part, by normalization of presynaptic plasticity at orexin cells that occurs as a result of cocaine exposure. This article is part of the Special Issue entitled 'Hypothalamic Control of Homeostasis'.

Indexed as

AnimalsBehavior, AddictiveCocaineHypothalamic Area, LateralLocomotionMiceMice, Inbred C57BLMice, TransgenicMicroinjectionsOrexinsPropionatesRatsReceptors, Metabotropic GlutamateSelf Administration2-amino-4-phosphono-propinateCocaineHcrt protein, mousemetabotropic glutamate receptor 3OrexinsPropionatesReceptors, Metabotropic GlutamateDiscriminative stimulimglurPlasticityReinstatementWithdrawal

Identifiers

PMID30253175
PMCPMC6520213
OpenAlexW2897934795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.